Skip to Content
Be ready for a severe allergy emergency. Read more >>

Emedastine ophthalmic Pregnancy and Breastfeeding Warnings

Emedastine ophthalmic is also known as: Emadine

Emedastine ophthalmic Pregnancy Warnings

Animal studies using doses up to 15,000 times the maximum human ophthalmic dose have revealed no evidence of teratogenicity. Increased external, visceral and skeletal anomalies were observed in rats at doses 70,000 times the maximum recommended ocular dose. There are no controlled data in human pregnancy. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: B

See references

Emedastine ophthalmic Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes Comment: Apply pressure to the tear duct by the corner of the eye for at least 1 minute after eye drop instillation to limit systemic absorption; blot excess solution with tissue.

While this drug has been shown present in animal milk, it is not expected to cause harmful effects in human nursing infants. This drug is not expected to be absorbed systematically through topical ocular administration.

See references

References for pregnancy information

  1. "Product Information. Emadine (emedastine ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Emadine (emedastine ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide